Page last updated: 2024-11-05

thiethylperazine and Experimental Radiation Injuries

thiethylperazine has been researched along with Experimental Radiation Injuries in 2 studies

Thiethylperazine: A dopamine antagonist that is particularly useful in treating the nausea and vomiting associated with anesthesia, mildly emetic cancer chemotherapy agents, radiation therapy, and toxins. This piperazine phenothiazine does not prevent vertigo or motion sickness. (From AMA Drug Evaluations Annual, 1994, p457)
thiethylperazine : A member of the class of phenothiazines that is perazine substituted by a ethylsulfanyl group at position 2.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mattsson, JL2
Cordts, RE1
Yochmowitz, MG1
Hardy, KA1
Cooper, JR1

Other Studies

2 other studies available for thiethylperazine and Experimental Radiation Injuries

ArticleYear
Prevention of radiation emesis in dogs by combinations of drugs.
    International journal of radiation oncology, biology, physics, 1984, Volume: 10, Issue:7

    Topics: Animals; Antiemetics; Cimetidine; Dogs; Drug Therapy, Combination; Male; Promethazine; Radiation Inj

1984
Control of radiation-induced emesis with promethazine, cimetidine, thiethylperazine, or naloxone.
    American journal of veterinary research, 1979, Volume: 40, Issue:8

    Topics: Animals; Chemoreceptor Cells; Cimetidine; Dog Diseases; Dogs; Guanidines; Male; Naloxone; Promethazi

1979